Evidence map›Paper›PMID 32227559›Full record

ArticleMolecular reproduction and development2020

RS-1 enhances CRISPR-mediated targeted knock-in in bovine embryos.

I Lamas-Toranzo, A Martínez-Moro, E O Callaghan, G Millán-Blanca, J M Sánchez, P Lonergan, P Bermejo-Álvarez

Open access · hybridAbstract read
In one paragraph

Article in Molecular reproduction and development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Review
  19. Review
  20. RS-1 enhances CRISPR-mediated targeted knock-in in bovine embryos.Molecular reproduction and development · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

I Lamas-ToranzoAnimal Reproduction Department, INIA, Madrid, Spain.
A Martínez-MoroAnimal Reproduction Department, INIA, Madrid, Spain.
E O CallaghanSchool of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
G Millán-BlancaAnimal Reproduction Department, INIA, Madrid, Spain.
J M SánchezSchool of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
P LonerganSchool of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
P Bermejo-ÁlvarezAnimal Reproduction Department, INIA, Madrid, Spain.ORCID 0000-0001-9907-2626
Department of Animal Health · VNUniversity College Dublin · IEFundación de Estudios de Economía Aplicada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted knock-in (KI) can be achieved in embryos by clustered regularly interspaced short palindromic repeats (CRISPR)-assisted homology directed repair (HDR). However, HDR efficiency is constrained by the competition of nonhomologous end joining. The objective of this study was to explore whether CRISPR-assisted targeted KI rates can be improved in bovine embryos by exposure to the HDR enhancer RS-1. In vitro produced zygotes were injected with CRISPR components (300 ng/µl Cas9 messenger RNA and 100 ng/µl single guide RNA against a noncoding region) and a single-stranded DNA (ssDNA) repair template (100 ng/µl). ssDNA template contained a 6 bp XbaI site insert, allowing targeted KI detection by restriction analysis, flanked by 50 bp homology arms. Following microinjection, zygotes were exposed to 0, 3.75, or 7.5 µM RS-1 for 24 hr. No differences were noted between groups in terms of development or genome edition rates. However, targeted KI rates were doubled in the group exposed to 7.5 µM RS-1 compared to the others (52.8% vs. 25% and 23.1%, for 7.5, 0, and 3.75 µM, respectively). In conclusion, transient exposure to 7.5 µM RS-1 enhances targeted KI rates resulting in approximately half of the embryos containing the intended mutation, hence allowing direct KI generation in embryos.

Indexed as

Gene Knock-In TechniquesAnimalsAnimals, Genetically ModifiedBenzamidesCattleCells, CulturedCRISPR-Cas SystemsDNA Breaks, Double-StrandedDNA End-Joining RepairEmbryo Culture TechniquesEmbryo, MammalianGene EditingGene TargetingSulfonamides3-((benzylamino)sulfonyl)-4-bromo-N-(4-bromophenyl)benzamideBenzamidesSulfonamidesbovineDNA repairembryogene editingRS-1

Identifiers

PMID32227559
PMCPMC7496720
OpenAlexW3012967003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.